Science & Services

Science

We are developing high-precision liquid-based diagnostic technology based on "single enzyme activity-based protein profiling (SEAP)," which can evaluate the activity of various enzymes in the blood molecule at single protein level.

Services

Our business focuses on 2 main areas: early disease diagnosis and supp

Mission Vision Value

Mission

We will contribute to future growth of healthcare by applying fluorescent enzyme substrates and microdevices.

Vision

Creating a world without disease and people living life to the fullest

In a world where disease can be detected at an early stage

An cured with the perfect, effective remedy suitable for each individual

No one is afflicted by disease

To realize such future, we will continue to take up the challenge

Value

We act based on our four values (FULL RESPECT,HIGHEST PERFORMANCE,WORTHY CHALLENGE,and SCIENCE FIRST) and aim to be a company that you can trust.

FULL RESPECT
 - Understand and respect each other from the bottom of our hearts!

HIGHEST PERFORMANCE
 - Maximize our teamwork for the best performance!

WORTHY CHALLENGE
 - Continue to take on challenges that are valuable to ourselves and Cosomil!

SCIENCE FIRST
 - Let us bring out trustworthy products to the world!

Team

Leaders

鏡味 優 Ph.D. CEO / 代表取締役

Yu Kagami, Ph.D.

CEO & Co-Founder

Yu Kagami, the co-founder of our company in April 2022, has served as CEO since incorporation. Prior to co-founding our company, Yu was engaged in drug review work at the Pharmaceuticals and Medical Devices Agency (PMDA) and in regulatory affairs, clinical development at Janssen Pharmaceuticals. Yu received a Ph.D. in 2016 at the Graduate School of Pharmaceutical Sciences of the University of Tokyo in research on the development of fluorescent dyes.

坂本 眞伍 Ph.D.  CTO / 最高技術責任者

Shingo Sakamoto, Ph.D.

CTO & Co-Founder

Shingo Sakamoto, Ph.D., the co-founder of our company in April 2022, has served as CTO since incorporation. Shingo has been developing the single enzyme activity-based protein profiling (SEAP) technology since he began his research at the Faculty of Pharmaceutical Sciences of the University of Tokyo. Shingo received the Grand Prize, HAX Tokyo Award, and Mentor Award in the "Entrepreneurship Development" section of EDGE-NEXT Development of MEXT in 2020.

宇野 寿洋 CBO / 最高事業責任者

Toshihiro Uno

CBO

Toshihiro Uno has served as Chief Business Officer since October 2023. Prior to joining Cosomil, he had multiple experiences such as Marketing Director at Janssen Pharmaceuticals, responsible for Strategic Marketing of New Products for Oncology across Asia Pacific Region as well as in Japan, followed by Commercial Operations Director at Abbott, responsible for driving competitiveness of sales organization. He started his career as Sales Rep followed by Marketing Brand Leader at pharmaceutical companies after graduating from University of Houston. He aspires to contribute to conquering cancer while spending most of his career in Oncology.

Advisors

小松 徹  化学分野

Toru Komatsu, Ph.D.

Chemistry

Toru Komatsu, Ph.D., the co-founder of our company in April 2022, has served as Scientific Advisor since incorporation. Currently, Toru is an associate professor at the Graduate School of Pharmaceutical Sciences of the University of Tokyo after working as a postdoctoral fellow at Johns Hopkins University and Scripps Research Institute in the U.S. He also served as a JST-PRESTO researcher (concurrent position) from 2013 to 2017. Toru specializes in chemical biology and drug discovery chemistry.

渡邉 力也 工学分野

Rikiya Watanabe, Ph.D.

Engeneering

Rikiya Watanabe, Ph.D., the co-founder of our company in April 2022, has served as Scientific Advisor since incorporation. After working as an assistant professor and lecturer at the Graduate School of Engineering of the University of Tokyo, and as a JST PRESTO researcher (concurrent position), Rikiya is currently a chief scientist at RIKEN, and an adjunct professor at the Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University. Rikiya specializes in single molecule biophysics and bioMEMS.

水野 忠快      計算科学分野

Tadahaya Mizuno, Ph.D.

Bioinformatics

Tadahaya Mizuno, Ph.D. is an Assistant Professor in the Department of Molecular Pharmacokinetics at the Graduate School of Pharmaceutical Sciences of the University of Tokyo. He specializes in bioinformatics and chemoinformatics.

本田 一文  臨床分野・バイオマーカー開発

Kazufumi Honda, D.D.S., Ph.D.

Clinical Biomarker

After serving as Assistant Professor of Oral Surgery at Tokyo Medical University, Postdoctoral Fellow at PMDA, Laboratory Head and Unit Director at the National Cancer Center Research Institute, and Director of the Division of Early Diagnostic Biomarker Development at the same institute, Kazufumi is currently a Graduate Professor at the Department of Bioregulation, Graduate School of Medicine, Nippon Medical School. He specializes in tumor biology and biomarker discovery.

Company

Company Name
Cosomil, Inc.
Company Number
5010001225722
Establishment
April 1, 2022
Representative
Yu Kagami, Representative Director
Adress
Entrepreneur Lab, South Clinical Research Bldg., 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8485, Japan
TEL
+81-3-6823-2260
FAX
+81-3-6823-2261
Description of Business
Early detection of diseases and support for drug development by single molecule imaging of enzyme activity
Capital
2,250,000 JPY
Number of Employees
15 (as of Jun. 1, 2024)
Investors
ANRI, Coral Capital, Green Core, Angel Investor